The default category

Replay available – Webinar on imaging RPE cells and pigment migration

Interview & discussion with 3 ophthalmologists, first users of rtx1 with TFI optional module, about imaging RPE cells and pigment changes.

Euretina 2023 – New clinical findings presented by rtx1 users

This year at Euretina, four teams who use rtx1 AO cameras present novel study results in inherited retinal diseases, diabetic…

New insight into AMD progression presented at CRATER

At the CRATER Conference in Warsaw, Poland, Prof. Michel Paques gave an update on clinical research on AMD, conducted by…

New solutions for AO imaging presented at ARVO

During ARVO 2023 in New Orleans, we were thrilled to present and discuss in person our solutions for cellular-resolution…

ARVO 2023 – rtx1 users present new clinical findings

This year, users of the rtx1 AO cameras will introduce new biomarkers and methods for AO studies, as well as novel clinical…

Many thanks to customers who presented at ISER 2023

Last week at the ISER 2023 biennal meeting, users of Imagine Eyes' retinal imaging devices have shared their work and findings…

Great presentations at the AO-Vision symposium !

Last week, rtx1 users presented their work in IRDs at the AO-vision symposium.

Imagine Eyes appoints Maelys Bellay as QA/RA specialist

Maelys Bellay recently joined our Quality Assurance and Regulatory Affairs (QA/RA) team at Imagine Eyes. “I am happy to…

Imagine Eyes selected for Bpifrance accelerator program

We are happy to share that Imagine Eyes is laureate for a second accelerator program in less than one year! This month,…

Imagine Eyes to meet pharmas to speed up the development of therapies

To accelerate the clinical development of new retinal treatments, we propose to implement advanced retinal imaging technology…